In older adults with severe AS and complex CAD, PCI + TAVI vs. SAVR + CABG reduced patient-oriented outcomes at 1 y
Related Experiment Video
Updated: May 16, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Paolo Ciacci1, Giulio Francesco Romiti2, Bernadette Corica3
1Università Campus Bio-Medico, Rome, Italy (P.C.).
Insights
This study investigates the clinical impact of specific formulas in General Internal Medicine, Family Practice, and General Practice. Findings are crucial for updating clinical guidelines and improving patient care across primary care settings.
Area of Science:
- Cardiology
- General Internal Medicine
- Family Practice
- General Practice
Background:
- Clinical impact ratings are essential for evidence-based medicine.
- Formulas in primary care require continuous evaluation for relevance and accuracy.
Purpose of the Study:
- To assess the clinical impact of specific formulas in General Internal Medicine, Family Practice, and General Practice.
- To provide data supporting the refinement of clinical decision-making tools.
Main Methods:
- Analysis of clinical impact ratings based on provided formulas.
- Evaluation across General Internal Medicine, Family Practice, and General Practice domains.
Main Results:
- Specific formulas demonstrated significant clinical impact in Cardiology.
- Formulas relevant to General Internal Medicine, Family Practice, and General Practice were identified.
Conclusions:
- The evaluated formulas hold clinical relevance in primary care.
- These findings can inform future updates to clinical practice guidelines.
Clinical Impact Ratings:
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

